FACT II Acquisition Corporation (FACT)

Correction: Precision Aerospace & Defense Group Announces Letter of Intent with Leader in Communications, Security and Surveillance Integration Solutions

Proposed Strategic Acquisition Represents a Major Industry Expansion as Company Advances Toward Public Listing Overland Park, KS, June 09, 2026...

Precision Aerospace & Defense Group Announces Letter of Intent with Leader in Communications, Security and Surveillance Integration Solutions

Proposed Strategic Acquisition Represents a Major Industry Expansion as Company Advances Toward Public Listing Overland Park, KS, June 05, 2026...

Precision Aerospace & Defense Group, Inc. and FACT II Acquisition Corp. File Amended Registration Statement on Form S-4 in Connection with Proposed Business Combination

Overland Park, KS and New York, NY, May 19, 2026 (GLOBE NEWSWIRE) -- Precision Aerospace & Defense Group, Inc. (“PAD”), a high-growth...

Precision Aerospace & Defense Group, Inc. and FACT II Acquisition Corp. Announce Filing of Amended Registration Statement on Form S-4 in Connection with Proposed Business Combination

Precision Aerospace & Defense Group, Inc. (“PAD”), a high-growth aerospace & defense engineering and manufacturing company, and FACT II...

Precision Aerospace & Defense Group to Host Investor Day on February 25, 2026

Precision Aerospace & Defense Group, Inc. (“PAD” or the “Company”), a high-growth aerospace & defense engineering and manufacturing firm...

Precision Aerospace & Defense Group, Inc. to Combine with FACT II Acquisition Corp. to Become Publicly Listed Company

Highlights Precision Aerospace & Defense Group, Inc. (“PAD”) to merge with FACT II Acquisition Corp. (NASDAQ: FACT) (“FACT”), creating a...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Facet Biotech Announces Two Presentations at American Academy of Neurology Annual Meeting

REDWOOD CITY, CA -- (Marketwire) -- 04/05/10 -- Facet Biotech Corporation (NASDAQ: FACT) today announced that data for the company's daclizumab...

PDL BioPharma Clarifies $13.00 Cost Basis in Facet Biotech Corporation

PDL BioPharma Clarifies $13.00 Cost Basis in Facet Biotech Corporation PR Newswire INCLINE VILLAGE, Nev., March 24 INCLINE VILLAGE, Nev., March...

Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Facet Biotech Corporation by Abbott Laboratories

Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of...